IQVIA (IQV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - IQVIA Holdings reported $3.83 billion in revenue for Q1 2025, a year-over-year increase of 2.5$2.70, up from $2.54 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of$3.77 billion by 1.55%, and the EPS also surpassed the consensus estimate of $2.63 by 2.66$31.5 billion, slightly above the average estimate of 31.43 billion from two analysts [4] - Revenue from Technology & Analytics Solutions was 1.55 billion, exceeding the estimated $1.52 billion, reflecting a 6.4$2.10 billion, slightly above the $2.08 billion estimate, with a year-over-year change of 0.3$181 million, below the estimated $183.42 million, showing a year-over-year decline of 4.2$360 million, compared to the estimated 365.56 million [4] - Segment profit for Contract Sales & Medical Solutions was 11 million, below the estimated 15.65 million [4] - Segment profit for Research & Development Solutions was 460 million, compared to the estimated $471.69 million [4] Stock Performance - IQVIA shares have returned -0.5% over the past month, while the Zacks S&P 500 composite increased by 11.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]